Beautiful Virgin Islands

Wednesday, Aug 27, 2025

Pfizer testing COVID treatment pill

Pfizer testing COVID treatment pill

Pfizer, maker of the most widely-used COVID-19 vaccine in the U.S., is testing a potential pill-based treatment for the virus using the same class of medication typically used to treat HIV.
Pfizer announced the beginning of a phase 1 clinical trial using a protease inhibitor pill as a treatment for the virus on Tuesday. News of the trial comes months after Pfizer's COVID-19 vaccine, made in collaboration with the German firm BioNTech, was approved for use and began to be administered in the U.S. and several other countries. The pill, currently dubbed PF-07321332, could offer an additional weapon against the virus as fast-moving mutations threaten to weaken the effectiveness of vaccines.

"Tackling the COVID-19 pandemic requires both prevention via vaccine and targeted treatment for those who contract the virus," Pfizer's Chief Scientific Officer Mikael Dolsten said in a statement obtained by Newsweek. "Given the way that SARS-CoV-2 is mutating and the continued global impact of COVID-19, it appears likely that it will be critical to have access to therapeutic options both now and beyond the pandemic."

"We have designed PF-07321332 as a potential oral therapy that could be prescribed at the first sign of infection, without requiring that patients are hospitalized or in critical care," added Dolsten.

The drug has shown activity against the virus that causes COVID-19 in test tube experiments, as well as activity against other types of coronaviruses, with the company saying that the results raise the possibility of "potential use to address future coronavirus threats."

Dolsten touted both the oral medication and the company's previously-developed experimental protease inhibitor treatment designed to be administered to hospitalized COVID-19 patients intravenously, which is currently undergoing phase 1b trials. Dolsten said that that two different approaches offer "the potential to create an end to end treatment paradigm that complements vaccination in cases where disease still occurs."

While none of the vaccines offer total protection against contracting the virus, they have been shown to significantly reduce infections and to be extremely effective in preventing hospitalizations and death. Treatment options could help mitigate concerns posed by the fact that some of the mutations currently making their way around the world have shown a limited amount of resistance to the vaccines, although both Pfizer and Moderna are developing booster shots or new versions of vaccines to combat emerging variants.

As of Tuesday, over 64.6 million people in the U.S. had received at least one dose of the Pfizer-BioNTech vaccine, according to the Centers for Disease Control and Prevention. Moderna's vaccine was not far behind, with around 60.9 million doses administered, while the single-dose Johnson & Johnson vaccine had gone into the arms of just under 2.5 million people.

Protease inhibitors, which block virus reproduction by binding to proteins called protease, were a class of drugs that revolutionized HIV treatment in the mid-1990s. They are key components in the multi-drug "cocktail" therapies that changed HIV from an infection that almost invariably led to AIDS and death to a condition that can typically be survived if treatments are available and used regularly. The drugs are also used against Hepatitis C infections, while researchers have investigated their use as treatments for certain types of cancer and parasitic infections.
Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Manhunt in Australia: Armed Anti-Government Suspect Kills Police Officers Sent to Arrest Him
China Launches World’s Most Powerful Neutrino Detector
How Beijing-Linked Networks Shape Elections in New York City
Ukrainian Refugee Iryna Zarutska Fled War To US, Stabbed To Death
Elon Musk Sues Apple and OpenAI Over Alleged App Store Monopoly
2 Australian Police Shot Dead In Encounter In Rural Victoria State
Vietnam Evacuates Hundreds of Thousands as Typhoon Kajiki Strikes; China’s Sanya Shuts Down
UK Government Delays Decision on China’s Proposed London Embassy Amid Concerns Over Redacted Plans
A 150-Year Tradition to Be Abolished? Uproar Over the Popular Central Park Attraction
A new faith called Robotheism claims artificial intelligence isn’t just smart but actually God itself
Deputy Prime Minister Angela Rayner Purchases Third Property Amid Housing Tax Reforms Debate
HSBC Switzerland Ends Relationships with Over 1,000 Clients from Saudi Arabia, Lebanon, Qatar, and Egypt
Sharia Law Made Legally Binding in Austria Despite Warnings Over 'Incompatible' Values
Italian Facebook Group Sharing Intimate Images Without Consent Shut Down Amid Police Investigation
Dutch Foreign Minister Resigns Amid Deadlock Over Israel Sanctions
Trump and Allies Send Messages of Support to Ukraine on Independence Day Amid Ongoing Conflict
China Reels as Telegram Chat Group Shares Hidden-Camera Footage of Women and Children
Sam Nicoresti becomes first transgender comedian to win Edinburgh Comedy Award
Builders uncover historic human remains in Lancashire house renovation
Australia Wants to Tax Your Empty Bedrooms
MotoGP Cameraman Narrowly Avoids Pedro Acosta Crash at Hungarian Grand Prix
FBI Investigates John Bolton Over Classified Documents in High-Profile Raids
Report reveals OpenAI pitched national ChatGPT Plus subscription to UK ministers
Labour set to freeze income tax thresholds in long-term 'stealth' tax raid
Coca‑Cola explores sale of Costa coffee chain
Trial hears dog walker was chased and fatally stabbed by trio
Restaurateur resigns from government hospitality council over tax criticism
Spanish City funfair shut after serious ride injury
Suspected arson at Ilford restaurant leaves three in critical condition
Tottenham beat Manchester City to go top of Premier League
Bank holiday heatwave to hit 30°C before remnants of Hurricane Erin arrive
UK to deploy immigration advisers to West Africa to block fake visas
Nurse who raped woman continued working for a year despite police alert
Drought forces closures of England’s canal routes, canceling boat holidays
Sweet tooth scents: food-inspired perfumes surge as weight-loss drugs suppress appetites
Experts warn Britain dangerously reliant on imported food
Family of Notting Hill Carnival murder victim call event unmanageable
Bunkers, Billions and Apocalypse: The Secret Compounds of Zuckerberg and the Tech Giants
Ukraine Declares De Facto War on Hungary and Slovakia with Terror Drone Strikes on Their Gas Lifeline
Animated K-pop Musical ‘KPop Demon Hunters’ Becomes Netflix’s Most-Watched Original Animated Film
New York Appeals Court Voids Nearly $500 Million Civil Fraud Penalty Against Trump While Upholding Fraud Liability
Elon Musk tweeted, “Europe is dying”
Far-Right Activist Convicted of Incitement Changes Gender and Demands: "Send Me to a Women’s Prison" | The Storm in Germany
Hungary Criticizes Ukraine: "Violating Our Sovereignty"
Will this be the first country to return to negative interest rates?
Child-free hotels spark controversy
North Korea is where this 95-year-old wants to die. South Korea won’t let him go. Is this our ally or a human rights enemy?
Hong Kong Launches Regulatory Regime and Trials for HKD-Backed Stablecoins
China rehearses September 3 Victory Day parade as imagery points to ‘loyal wingman’ FH-97 family presence
Trump Called Viktor Orbán: "Why Are You Using the Veto"
×